Million Dollar Meds aims to find why drugs for such diseases are expensive and what can be done
A new UBC reporting project is investigating why Canadians who suffer from rare diseases sometimes pay thousands or even millions of dollars a year on treatment.
Million Dollar Meds is a collaboration between UBC’s graduate school of journalism and the school’s pharmaceutical sciences department and is looking at why costs are so high and how those costs could be alleviated.
